These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8190103

  • 1. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
    Piersen CE, True CD, Wells JN.
    Mol Pharmacol; 1994 May; 45(5):861-70. PubMed ID: 8190103
    [Abstract] [Full Text] [Related]

  • 2. 125I-2-[4-[2-[2-[(4-azidophenyl)methylcarbonylamino] ethylaminocarbonyl]ethyl]phenyl] ethylamino-5'-N-ethylcarboxamidoadenosine labels transmembrane span V of the A2a adenosine receptor.
    Piersen CE, True CD, Wells JN.
    Mol Pharmacol; 1994 May; 45(5):871-7. PubMed ID: 8190104
    [Abstract] [Full Text] [Related]

  • 3. Immunological characterization of adenosine A2A receptors in human and porcine cardiovascular tissues.
    Marala RB, Mustafa SJ.
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1051-7. PubMed ID: 9694968
    [Abstract] [Full Text] [Related]

  • 4. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S, Ongini E, Zocchi C, Kull B, Arslan G, Fredholm BB.
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of two affinity states of adenosine A2a receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine.
    Luthin DR, Olsson RA, Thompson RD, Sawmiller DR, Linden J.
    Mol Pharmacol; 1995 Feb; 47(2):307-13. PubMed ID: 7870039
    [Abstract] [Full Text] [Related]

  • 7. Identification of an A2a adenosine receptor domain specifically responsible for mediating short-term desensitization.
    Palmer TM, Stiles GL.
    Biochemistry; 1997 Jan 28; 36(4):832-8. PubMed ID: 9020781
    [Abstract] [Full Text] [Related]

  • 8. 125I-APE binding to adenosine receptors in coronary artery: photoaffinity labeling with 125I-azidoAPE.
    Hussain T, Linden J, Mustafa SJ.
    J Pharmacol Exp Ther; 1996 Jan 28; 276(1):284-8. PubMed ID: 8558444
    [Abstract] [Full Text] [Related]

  • 9. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D.
    Mol Pharmacol; 1994 Apr 28; 45(4):599-607. PubMed ID: 8183238
    [Abstract] [Full Text] [Related]

  • 10. Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261.
    Dionisotti S, Ferrara S, Molta C, Zocchi C, Ongini E.
    J Pharmacol Exp Ther; 1996 Sep 28; 278(3):1209-14. PubMed ID: 8819504
    [Abstract] [Full Text] [Related]

  • 11. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding.
    Varani K, Gessi S, Dalpiaz A, Ongini E, Borea PA.
    Br J Pharmacol; 1997 Sep 28; 122(2):386-92. PubMed ID: 9313951
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors.
    Ivanov AA, Palyulin VA, Zefirov NS.
    J Mol Graph Model; 2007 Jan 28; 25(5):740-54. PubMed ID: 17095272
    [Abstract] [Full Text] [Related]

  • 16. Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor.
    Kim J, Wess J, van Rhee AM, Schöneberg T, Jacobson KA.
    J Biol Chem; 1995 Jun 09; 270(23):13987-97. PubMed ID: 7775460
    [Abstract] [Full Text] [Related]

  • 17. Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.
    Jiang Q, Van Rhee AM, Kim J, Yehle S, Wess J, Jacobson KA.
    Mol Pharmacol; 1996 Sep 09; 50(3):512-21. PubMed ID: 8794889
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA, Doufexis M, Kapas S, Chhajlani V.
    Biochem Biophys Res Commun; 2001 Mar 09; 281(4):851-7. PubMed ID: 11237737
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.